About PGDx

Key Functional Leadership Team

Jennifer Dickey, PhD, RAC
Jennifer Dickey, PhD, RAC
Director, Regulatory & Quality

Dr. Jennifer Dickey has joined PGDx as Director of Regulatory and Quality.  Dr. Dickey comes with an impressive background having most recently been with the FDA as Senior Scientific Reviewer in the Molecular Genetics branch of the Office of In Vitro Diagnostics and Radiological Health. Dr. Dickey has more than 7 years of regulatory review experience and was Regulatory Affairs Certified (RAC) through the Regulatory Affairs Professional Society (RAPS) in 2012. Dr. Dickey has played a leadership role in several regulatory initiatives including serving as Chair of the Next Generation Sequencing-based Oncology Panels Public Workshop (February 25, 2016) and as lead reviewer for the first NGS-based assay (Illumina assay for cystic fibrosis).  Dr. Dickey has spoken at several association conferences on subjects such as Regulatory Review of NGS Assays; Potential Roles for NGS in Companion Diagnostics; FDA Review of NGS Technologies; Multi-Analyte NGS Assays; and Enabling NGS in Global Clinical Trials, additionally Dr. Dickey has co-authored numerous peer-reviewed articles.

Maura Kadan
Maura Kadan, RN, MSN, OCN
Director, Clinical Operations
Ms. Maura Kadan has over 10 years of experience in oncology nursing before joining PGDx. She served as a staff nurse on the Heme-oncology in-patient unit and the Clinical Program Manager for GI Malignancies at Johns Hopkins Hospital. Maura’s unique experience and skill set enables PGDx to connect patients and health care teams with resources needed to make informed choices. Maura earned B.S in Health and Physical Education from Roanoke College, and a B.S.N & M.S.N from John Hopkins University School of Nursing.
EK Kim
EK Kim, PhD
Director, Product Development
Dr. EK Kim joined Personal Genome Diagnostics as Director of Product Development in July 2017 from Roche Molecular Solutions. Previously, she served as Development Leader for Companion Diagnostic (CDx) products where she led teams in the development of multiple CDx franchises.  Dr. Kim received a Ph.D. in Biochemistry and completed her post-doctoral fellowship at Oak Ridge National Laboratory and the University of Arizona where she was appointed a Ford Foundation Fellow. Her research focused on microbial community interactions by employing paired metagenomic and metaproteomic approaches via mass spectrometry. 
Meg Naver
Meg Naver
Director, Human Resources
Meg Naver joined Personal Genome Diagnostics in May of 2017 as Director of Human Resources. Meg is an experienced human resources professional with 20 years' experience in building HR infrastructure, policy, and practices. She has experience with small to mid-sized start-up organizations as well as well-established organizations where she oversaw HR operations, talent acquisition, and training and development. She has worked in a variety of industries, including telecommunications, online media and utilities. Meg earned a BA from Franklin Pierce University and a master certificate in human resources from Cornell University.
Michelle Reid
Michelle Reid, PhD
Director, Service and Support
Dr. Michelle Reid joined Personal Genome Diagnostics as director of service and support in June 2017 from QIAGEN Inc. Michelle has more than 17 years' experience in customer support in molecular diagnostics and research environments. While at QIAGEN she held a number of roles of increasing responsibilities, including technical support, marketing, and field service support. Most recently, Michelle was senior director of field service, in which she developed and led a service support team of more than 180 engineers, technicians, application specialists, and dispatch and repair centers. Her team supported more than 10,000 platforms, maximizing customer "up-time" for QIAGEN and its partners' automation. Michelle also played key roles in the strategic development of QIAGEN's field support team in Brazil and Mexico, and she developed field automation support for partners such as Abbott Diagnostics and INOVA. Prior to joining QIAGEN, Michelle held various positions in molecular sales and research. She received her PhD from LaTrobe University (Melbourne, Australia) in the molecular study of metastasis. She completed a post-doctoral fellowship at Flinders University (Adelaide, Australia) studying the impact of growth factors on nerve regeneration.
John Simmons
John Simmons, PhD
Director, Translational Science and Diagnostics

Dr. John Simmons joined Personal Genome Diagnostics in 2016 and serves as the Director of Translational Science and Diagnostics. In this role, John focuses broadly on scientific strategy and diagnostics partnerships with pharma/biotech.  Previously, John was at the National Cancer Institute where his research focused on identifying novel therapeutic strategies for multiple myeloma through chemical genomic approaches with a particular focus on drug combinations. He received his undergraduate degree in Biology with honors from American University and Ph.D. in Tumor Biology from Georgetown University as part of the NIH Graduate Partnership Program. As a post-doctoral fellow, he received the Multiple Myeloma Research Foundation (MMRF) Research Fellow award to support his work in developing systems-level approaches for drug combination identification and prioritization.

Chad Travers
Chad Travers
Director, Talent and Growth
Chad Travers joined Personal Genome Diagnostics September 2016 as Director of Talent and Growth.  In this capacity, he develops and implements talent attraction and assessment strategies that help drive superior organizational performance.  Over his 19 year career in the Health Sciences, he has hired and placed over 1,000 people across all functions from the C-suite to entry level in the Diagnostics, Medical Device, Biotechnology, Life Sciences, Pharmaceutical, and Medical Distribution sectors.  Prior to his medical career, Chad attended The University of Kansas where he received his Bachelors in Molecular Biology.